The SCFSkp2 ubiquitin ligase complex modulates TRAIL-R2-induced apoptosis by regulating FLIP(L)

Jamie Z Roberts1, Caitriona Holohan1, Tamas Sessler1

  • 1Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.

Insights

This study reveals how the SCFSkp2 complex targets FLIP(L) for degradation at the TRAIL-R2 death-inducing signaling complex (DISC), enhancing apoptosis. Inhibiting Cullin-1 boosts TRAIL-induced cell death by stabilizing FLIP(L).

Area of Science:

  • Cellular Biology
  • Molecular Oncology
  • Immunology

Background:

  • TRAIL-R2 (DR5) is a crucial target for cancer therapies and immune cells.
  • The Skp1-Cullin-1-F-box (SCF) Cullin-Ring E3 Ubiquitin Ligase complex, specifically SCFSkp2, plays a role in protein degradation.
  • Understanding the regulation of TRAIL-R2 signaling is vital for developing effective cancer treatments.

Purpose of the Study:

  • To elucidate the novel interaction between TRAIL-R2 and the SCFSkp2 E3 ubiquitin ligase complex.
  • To investigate the role of this interaction in regulating TRAIL-R2-mediated apoptosis.
  • To identify the specific components involved in this regulatory pathway and their functional consequences.

Main Methods:

  • Co-immunoprecipitation assays to detect protein-protein interactions.
  • Western blotting to analyze protein levels and modifications (e.g., ubiquitination, NEDDylation).
  • RNA interference (siRNA) to silence specific genes and pharmacological inhibition (MLN4924) to block NEDDylation.

Main Results:

  • SCFSkp2 interacts with both the pre-ligand association complex (PLAC) and the ligand-activated death-inducing signaling complex (DISC) of TRAIL-R2.
  • Inhibition of Cullin-1's DISC recruitment via NEDDylation inhibition increased TRAIL-induced apoptosis.
  • FLIP(L) interacts with Cullin-1 and Skp2, and its processing to p43-FLIP(L) enhances this interaction, promoting ubiquitination and degradation, and modulating TRAIL-R2 signaling.

Conclusions:

  • The SCFSkp2 complex targets FLIP(L) for degradation at the TRAIL-R2 DISC.
  • Processing of FLIP(L) to p43-FLIP(L) is a critical step for its interaction with SCFSkp2 and subsequent turnover.
  • Modulating this SCFSkp2-FLIP(L) interaction offers a potential strategy to enhance TRAIL-R2-mediated apoptosis in cancer therapy.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
7.8K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.0K
Anaphase Promoting Complex00:50

Anaphase Promoting Complex

The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.3K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.6K
Protein Complexes with Interchangeable Parts01:57

Protein Complexes with Interchangeable Parts

Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K